“The Cost-Effectiveness of Losartan in Type 2 Diabetics With Nephropathy in Switzerland - an Analysis of the RENAAL Study”. Swiss Medical Weekly 134, no. 3132 (August 7, 2004): 440–447. Accessed November 4, 2025. https://smw.ch/index.php/smw/article/view/399.